Business Wire

Allison Unveils New Brand Identity to Reflect Agency’s Evolution

6.9.2023 13:00:00 EEST | Business Wire | Press release

Share

After more than two decades of remarkable growth and evolution, Allison (fka Allison+Partners) is excited to unveil its new brand identity, complete with a new name, logo, website and visual identity. The rebranding effort reflects the agency's transformation from its origin as a traditional PR firm focused on earned media to a modern integrated marketing and communications powerhouse with a global presence.

"Today marks a significant milestone in our history,” says Scott Allison, global chairman and CEO of Allison. “The unveiling of our new brand identity represents not just a change in name and logo, but a bold declaration of our commitment to shaping the future of integrated marketing and communications. We have evolved alongside the industry, embracing innovation and expanding our global footprint. This rebranding is a testament to our team's dedication to excellence, creativity, and the relentless pursuit of solutions that drive meaningful impact for our clients. With Allison, we are poised to lead the way in a new era of communications."

Why Rebrand? Why Now?

Over the past 22 years, Allison has undergone a remarkable evolution, expanding its services, client portfolio and talent base to encompass a diverse range of expertise, from to creative solutions. The agency also saw significant growth in the number of global assignments —with seven of its top 10 clients now represented across multiple markets—and an enhanced client roster of global brands, such as AB InBev, GE Appliances, Hewlett Packard Enterprise, IHG, Kyndryl and Revlon. This rebranding initiative is a response to the need for a refreshed brand identity that aligns with the agency's current and future trajectory, while highlighting its unique culture, global reach, integrated capabilities and forward-thinking approach. Visit the new website at www.allisonworldwide.com to explore the refreshed brand identity and learn more about Allison's innovative solutions.

Solving Fragmentation and Embracing Innovation

The rebranding also aims to address the challenge of fragmentation that has naturally occurred as the agency has grown and the marketing landscape has evolved, potentially diluting or blurring the agency's points of differentiation. By simplifying and unifying the brand story, Allison will better convey its ability to solve complex business challenges, attract top talent, and provide integrated marketing and communications on a global scale. The new brand identity not only celebrates the agency's growth but also positions it as a driver of the industry's future innovations.

A Fresh and Modern Identity Built In-House

Allison’s Brand and Engagement Strategy Team led the new brand identity, using its approach to research, strategy and branding for clients called V.I.T.A.L, which is a framework that helps companies understand and express a brand’s humanity (and therefore build engagement). The new brand features a sleek and modern logo that signifies the agency's evolution and commitment to innovation. The cutout in the I represent the agency’s vision of always moving forward with innovation and a commitment to excellence. The name change to "Allison" showcases a more inclusive and contemporary identity, while paying homage to the agency's founders and their values. The removal of "+Partners" reflects the team-oriented approach Allison has always been known for, emphasizing the agency's focus on inclusion, unity and diversity.

Forward-Looking Vision

With the rebrand, Allison sets its sights on its evolution to a fully integrated marketing and communications consultancy. Its Marketing Innovation Team offers integrated marketing, brand engagement strategies, performance marketing, creative, Storytelling Studio, and research and analytics functions, while its Allison Advisory team helps the C-suite accelerate growth by finding and optimizing the intersection of business goals, customer needs, regulatory environments and employee experience. The agency plans to bolster its creative capabilities, achieve rapid growth through targeted acquisitions, and continue to expand its service offerings beyond its PR roots driving innovation through a deep expertise in data and technology.

Brand Manifesto, Mission, Vision, and Purpose

The new brand manifesto, Always Forward, speaks to the agency's dedication to agility, innovation and forward momentum. The mission underscores that it's all about the work—unlocking insights, inspiring innovation and building meaningful connections. The vision and purpose highlight Allison's commitment to a limitless environment where everyone can build, create and grow, while using creativity to drive positive change and business success.

Agency Solutions

At the heart of the rebrand is a profound shift towards enhanced client offerings. Every solution is thoughtfully crafted to address the unique challenges our clients face in today's ever-changing global marketplace. By immersing ourselves in our clients' issues, Allison transcends the boundaries of conventional marketing, emerging as problem solvers and trusted partners. With this new approach, Allison emphasizes its ability to drive awareness and demand, increase cultural relevance, build and protect reputations, transform brands, and elevate business performance for clients across the globe. The solutions are not just services; they are pathways to success, strategies to create change and blueprints for navigating the dynamic marketing landscape.

With this rebrand, Allison is poised to embark on an exciting new chapter, while respecting the legacy of growth that has made it one of the greatest success stories in the industry over the past 22 years, showcasing its evolution, innovation and commitment to always move forward. The new brand identity captures the agency's spirit and dedication, ensuring it remains at the forefront of the industry for years to come.

About Allison

Allison is a global integrated marketing and communications consultancy, dedicated to driving growth, innovation, and positive change for clients, colleagues, and communities. With a diverse range of expertise and a forward-looking mindset, Allison delivers game-changing results that make a lasting impact. Allison is owned by Stagwell (NASDAQ: STGW), one of the fastest growing and most influential marketing and communications networks in the world. Agency partners leverage Stagwell’s technology, data analytics, insights and strategic consulting solutions to drive measurable results and optimize return on marketing investment for more than 1,700 clients worldwide. Learn more at www.allisonworldwide.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media inquiries:

Shanna Brown
Shanna.Brown@allisonworldwide.com
646.428.6837

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 17:50:00 EEST | Press release

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive

emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 18:12:00 EEST | Press release

emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead

Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 16:00:00 EEST | Press release

Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme

EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 16:00:00 EEST | Press release

European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea

ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 15:00:00 EEST | Press release

ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye